Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting
ConclusionThe current article will serve as a comprehensive guide for optimizing the management of HR + HER2 − mBC. The proposed breast cancer registry will help identify unmet needs and develop strategic regional policies to help improve access to optimized care for HR + HER2 − mBC.
Source: BMC Proceedings - Category: Biomedical Science Source Type: research
More News: Argentina Health | Biomedical Science | Brazil Health | Breast Cancer | Cancer | Cancer & Oncology | Colombia Health | Endocrine Therapy | HER2 | Hormones | Mexico Health | Ovarian Cancer | Ovaries | Singapore Health | South Korea Health | Taiwan Health | Women